Adjuvant concurrent docetaxel, epirubicin and cyclophosphamide chemotherapy in breast cancer: The TEC regimen. A retrospective analysis Journal title: Journal of Cancer Research & Therapy Authors: Galdy S, Zenoni D, Galmozzi A, Mauri CM, Cazzaniga S Subject(s): Oncology
